Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review]. [electronic resource]
- Endocrine journal Jul 2016
- 597-602 p. digital
Publication Type: Journal Article; Review
1348-4540
10.1507/endocrj.EJ16-0064 doi
Adenocarcinoma--drug therapy Chemotherapy, Adjuvant Disease Progression Humans Iodine Radioisotopes--therapeutic use Neoplasm Metastasis Neoplasm Recurrence, Local Protein Kinase Inhibitors--therapeutic use Protein-Tyrosine Kinases--antagonists & inhibitors Thyroid Neoplasms--drug therapy Treatment Failure